Treatment of elevated C4a in patients with CFS using low doses of erythropoietin safely reduces symptoms and lowers C4a: a prospective clinical trial 2007, IACFS (conference peer review)
Shoemaker R, Maizel M2007
HematologicalImmune/InnateNeurological
Summary
No abstract is available for this paper. It was published in 2007 by Shoemaker R and colleagues. CIRS Nexus tags it under Hematological, Immune/Innate, Neurological.
Part of CIRS biomarkers research · Curated by Lauren Lowenstein, The Biotoxin Lady
Key Biomarkers
Symptom Clusters
CFS symptoms
Related Papers
- A Transcriptomic Fingerprint for Parkinson's Disease Found in Patients with Chronic Inflammatory Response Syndrome: Implications for Diagnosis, Treatment and PreventionMedical Research Archives · 2024 · 3 shared tags
- Malignancies in Patients with Celiac Disease: Diagnostic Challenges and Molecular AdvancesGenes · 2023 · 3 shared tags
- Current Understanding of the Pathophysiology and Novel Treatments of Interstitial Cystitis/Bladder Pain SyndromeBiomedicines · 2022 · 3 shared tags
- Chronic Diarrhea and Weight Loss in an 18-month-old BoyPediatrics in Review · 2021 · 3 shared tags
- Altered Cytokine Response of Human Brain Endothelial Cells after Stimulation with Malaria Patient PlasmaCells · 2021 · 3 shared tags
- A Novel Therapeutic Approach to Parkinson's Disease: Using Transcriptomics to Identify Unique Patterns of Gene Expression including 'Triple Positives,' Toll receptors, and Endotoxin ExposureMedical Research Archives · 2025 · 3 shared tags